التفاصيل البيبلوغرافية
| العنوان: |
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer |
| المؤلفون: |
Leary, Alexandra, Estévez-García, Purificación, Sabatier, Renaud, Ray-Coquard, Isabelle, Romeo, Margarita, Barretina-Ginesta, Pilar, Gil-Martin, Marta, Garralda, Elena, Bosch-Barrera, Joaquim, Morán, Teresa, Martin-Martorell, Paloma, Nadal, Ernest, Gascón, Pere, Rodon, Jordi, Lizcano, Jose MAff12, Aff13, Muñoz-Guardiola, PauAff12, Aff14, Fierro-Durán, Gemma, Pedrós-Gámez, Oriol, Pérez-Montoyo, Héctor, Yeste-Velasco, Marc, Cortal, Marc, Pérez-Campos, Antonio, Alfon, Jose, Domenech, CarlesAff14, IDs12885024125015_cor24, Pérez-Fidalgo, Alejandro, Oaknin, Ana |
| المصدر: |
BMC Cancer. 24(1) |
| قاعدة البيانات: |
Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder